University of Malta
 

Published Papers
UOM Main Page
 
 
 
Apply - Admissions 2016
Newspoint
Malta Medical Journal
MPS

Agius Decelis D, Zarb Adami M, Galea J, Attard-Pizzuto M, Serracino-Inglott A, Azzopardi LM. Pharmacist intervention in pain management following heart surgery. Eur J Hosp Pharm published online 10 Sept 2014.

Aquilina A, Wirth F, Attard Pizzuto M, Grech L, Camilleri, L, Azzopardi LM et al. Preparing for pharmacist prescribing in Maltese hospitals. Journal of Pharmaceutical Health Services Research 2018. 

Aquilina S, Azzopardi LM, Serracino-Inglott A. Impacting Cardiovascular Disease Risk Management. Hospital Pharmacy Europe 2013; 68.

Attard D, Shoemake C, Vella J, Żmudzki P, Chłoń-Rzepa G, Wyska E. Evaluation and Optimization of In Silico Designed PDE4B Modulators. American Journal of PharmTech Research. 2016; 6(5). 

Attard Pizzuto M, Serracino-Inglott A, Azzopardi LM. Practices and Perceptions of Medical Practitioners on Potential Antibiotic Prescribing by Pharmacists. Journal of Pharmaceutical Health Services Research 2016; 7: 157-64.

Attard Pizzuto M, Camilleri L, Azzopardi LM, Serracino-Inglott A. Exploring views of pharmacists on antibacterial prescribing: a Maltese perspective. International Journal of Pharmacy Practice. 2018.

Azzopardi LM, Serracino-Inglott A, Salek S, Zarb-Adami M.  Development of external methods to evaluate the quality of pharmacy services offered by community pharmacists.  Quality Assurance Journal 2003; 7(4):  248-2257.

Azzopardi LM.  Medications management in older persons:  What can be achieved in the international community?  Home Health Care Services Quarterly 2005; 24:  137-146.

Baldacchino S, Camilleri L, Fava S, Serracino-Inglott A, Azzopardi LM. Risk Assessment Models for the Development of Complications in Maltese Type 2 Diabetic Patients. J Diabetes Metab 2013; 4(2): 1-6. 

Bonavia S, Shoemake C. Design and optimisation of novel Huperzine A analogues capable of modulating the acetylcholinesterase receptor for the management of Alzheimer’s disease. Journal of Pharmacognosy and Phytotherapy 2016; 8(5): 99-108. 

Borg JJ, Anker SD, Rosano G, Serracino-Inglott A, Strasser F. Multimodal management as requirement for the clinical use of anticachexia drugs - a regulatory and a clinical perspective. Curr Opin Support Palliat Care 2015; 9(4): 333-45.

Borg JJ, Tanti A, Kouvelas D, Lungu C, Pirozynski M, Serracino-Inglott A, Aislaitner G. European Union pharmacovigilance capabilities: potential for the new legislation. Ther Adv Drug Saf. 2015. Ther Adv Drug Saf. 2015; 6(4): 120-40.

Borg L, Xuereb K, Shoemake C. Evaluation and Optimization of In Silico Designed β-Secretase Modulators for the Treatment of "Alzheimer's Disease". AJPHR 2016; 4(10): 102-104.

Brincat A, Azzopardi LM, Zarb Adami M, Serracino-Inglott A. Development and evaluation of a Drug Information Bulletin. JPHSR 2014; 5(2): 81–88. 

Brincat Ruffini L, Azzopardi LM, Serracino-Inglott A. Perception of Use of Liquid Capsules. The Synapse published online 13 Oct 2014. 

Bugeja A, Attard Pizzuto M, Serracino-Inglott A, Azzopardi LM. Pharmacist intervention in a psychiatric setting. Eur J Hosp Pharm 2015; 0:1–5. doi:10.1136/ejhpharm-2014-000564

Bugeja NJ, Shoemake CM. Generating a Homology Model of the Human M1 Muscarinic Receptor and the Design of Cognate Modulators at this Locus for the Management of Alzheimer’s Disease. 2015; 6(9): 86-91. 

Buhagiar L, Cassar OA, Brincat MP, Buttigieg GP, Serracino-Inglott A, Zarb-Adami M, Azzopardi LM. Predictors of post-caesarean section pain and analgesic consumption. Journal of Anaesthesiology Clinical Pharmacology 2011; 27 (2): 185-191.

Busuttil-Griffin F, Shoemake C, Attard E, Azzopardi LM. Crude Fibre Determination of Malva sylvestris L. and Evaluation of its Faecal Bulking and Laxative Properties in Rats. International Journal of Biology 2015; 7(4).

Camilleri A, Serracino-Inglott A, Azzopardi LM. Extemporaneous Preparations from the Past. Pharmaceutical Historian 2015; 45(2): 41-44.

Captur C, Azzopardi LM, Serracino-Inglott A. Health-related quality of life and hormone replacement therapy. Hospital Pharmacy Europe 2013; 70. 

Caruana C, Shoemake C. A Structure-Based Drug Design Approach for the Identification of Novel Selective Cyclooxygenase-2 Inhibitors using Resveratrol Analogues as Lead Molecules. BioMirror 2015; 6(10): 100-113.

Cassar M, Shoemake C, Azzopardi LM, Saliba C, Gutierrez G. de novo Design of Non-Steroidal Oestrogen Receptor Modulating Molecules using Maltanedienol as a Lead Molecule. International Journal of Drug Design and Discovery 2013; 4(1): 965-977. 

Chetcuti M, Serracino-Inglott A, Flores G, Borg JJ. Pharmaceutical issues during the review of European Marketing Authorisation Applications in Malta. Pharmaceutical Development and Technology 2018; 23(6): 561-572.

Ciantar J, Shoemake C, Mangani C, Azzopardi LM, Serracino Inglott A. Optimisation of Tyrosine-based Lead Molecules capable of modulation of the Peroxisome proliferator-activated receptor gamma. International Journal of Pharmaceutical Sciences and Research 2012; 3(8): 2550-2561.

Cilia M, Ruiz S, Richardson P, Salmonson T, Serracino-Inglott A, Wirth F et al. Quality Issues Identified During the Evaluation of Biosimilars by the European Medicines Agency’s Committee for Medicinal Products for Human Use. AAPS PharmSciTech 2017: 1-23. 

Conti L, Wirth F, Azzopardi L, Mallia C, Camilleri Vassallo F, Coleiro B, Cassar PJ, Cassar K, Azzopardi LM, Zarb-Adami M, Serracino-Inglott A. Pharmaceutical care aspects in systemic lupus erythematosus. Hospital Pharmacy Europe. March/April 2009; 43: 48-51. 

Ellul C, Shoemake C. Design of Novel Compounds with the Potential of Dual PPARγ/α Modulation for the Management of Metabolic Syndrome. Nuclear Receptor Research 2017; 4.

Farrugia D, Cilia M, Serracino-Inglott A. Analysis of Good Distribution Practice Inspection Deficiency Data of Pharmaceutical Wholesalers in Malta. The Journal of Pharmaceutical and Biopharmaceutical Contract Services. Sep/Oct 2018; 30-32.

Farrugia DL, Shoemake CM, Attard E, Azzopardi LM, Mifsud SJ. Investigative study on the angiotensin converting enzyme (ACE) inhibiting properties of the terpenoid extract of Crataegus monogyna using in silico models. Journal of Pharmacognosy and Phytotherapy 2013; 5(2): 34-37. 

Fenech J, Galea R, Serracino-Inglott A, Azzopardi LM. Management and Patient Knowledge of Osteoporosis. Journal of Applied Therapeutic Research 2011; 8: 101-106.

Galea S, Zarb Adami M, Serracino-Inglott A, Azzopardi LM. Pharmacist interventions in non-prescription medicine use. Journal of Pharmaceutical Health Services Research 2013.

Gauci M, Wirth F, Azzopardi LM, Serracino-Inglott A. Clinical pharmacist implementation of a medication assessment tool for long-term management of atrial fibrillation in older persons. Pharmacy Practice. 2019; 17(1): 1349. 

Gauci M, Wirth F, Camilleri L, Azzopardi LM, Serracino-Inglott A. Design and application of a medication assessment tool for secondary prevention of stroke. Int J Clin Pharm. 2017; 39 (5): 1008-1012. 

Gauci M, Wirth F, Camilleri L, Azzopardi LM, Serracino-Inglott A.  Assessing appropriateness of drug therapy in older persons: Development and application of a medication assessment tool for long-term management of atrial fibrillation. Pharmacy Practice 2017 Oct-Dec;15(4):1021. 

Ga​​uci M, Wirth F, Azzopardi LM, Serracino-Inglott A. Clinical pharmacist implementation of a medication assessment tool for secondary prevention of stroke in older persons. Journal of Pharmaceutical Health Services Research 2018. 

Grech L, Coleiro B, Borg A, Serracino-Inglott A, Azzopardi LM. Evaluation of the Impact of A Pharmaceutical Care Service Offered to Rheumatoid Arthritis Patients Within an Ambulatory Setting. American Journal of Pharmacy and Health Research 2013; 1(7): 2321–3647.

Grech L, Ferrito V, Serracino-Inglott A, Azzopardi LM. 2015. Development and validation of RhMAT, as medication assessment tool specifically designed for rheumatoid arthritis management. Journal of Pharmaceutical Health Services Research 2015. 

Grech L, Ferrito V, Camilleri L, Serracino-Inglott A, Azzopardi LM. Pharmaceutical Care Models, Tools for Treating Patients with Rheumatoid Arthritis. The Rheumatologist 2016. 

Grima A, Shoemake C, Azzopardi LM, Serracino Inglott A. Optimisation of Abiraterone Based Non-Steroidal Lead Molecules. BioMirror 2012; 3(9): 1-8. 

Griscti S, Serracino-Inglott A, Zarb-Adami M, Azzopardi LM, Mallia C, Azzopardi L, Camilleri Vassallo F, Cassar PJ, Coleiro B, Cassar K, Aquilina D, Anastasi A. Management of rheumatoid arthritis. Hospital Pharmacy Europe March/April 2010; 49: 20-21. 

Gusman DH, Shoemake C. Evaluation and Optimization of in silico designed Sphingosine-1-Phosphate (S1P) Receptor Subtype 1 Modulators for the Management of Multiple Sclerosis. Yale J Biol Med. 2017 Mar; 90(1): 15–23. 

Magro L, Shoemake C, Serracino-Inglott A, Azzopardi LM. Chemical Enhancement of Fingerprints on Various Porous and Non-Porous Surfaces. Indian Journal of Forensic Medicine & Toxicology 2015; 9(1):225.

Mamo M, Wirth F, Azzopardi LM, Serracino-Inglott A. Standardising pharmacist patient-profiling activities in a rehabilitation hospital in Malta. Eur J Hosp Pharm 2014; 21:49-53.

Mason G, Wirth F, Cignarella A, Xuereb RG, Azzopardi LM. Antiplatelet and anticoagulant therapy for non-ST-elevation acute coronary syndromes in a general hospital. The Online Journal of Clinical Audits 2014; 6(3): 8-16. 

Mercieca C, Serracino-Inglott A, Azzopardi LM. Perceptions of a newsletter for community pharmacists. Journal of Pharmaceutical Health Services Research 2013; 4(2): 101-103. 

Mercieca M, Schembri F, Serracino-Inglott A, Azzopardi LM. Concept Design for Establishing an Eco-Friendly Pharmaceutical Production Facility in Malta. Pharmaceutical Technology 2016; 40(4): 38-49. 

Micallef B, Attard E, Serracino-Inglott A, Borg JJ. 2015. Could EU herbal monographs contribute to Malta’s treatment armamentarium? Phytomedicine 2015; 22(3): 400–405.

Micallef C, Shoemake C, Azzopardi LM. Creating a high-throughput screening database to propose ligands capable of modulating the HIV-1 protease receptor. Journal of AIDS and HIV Research 2013; 5(7):  224-234. 

Mifsud EM, Azzopardi LM, Serracino-Inglott A. Proposing a Framework for International Normalized Ratio Testing and Anticoagulation Management in Community Pharmacies. Point of Care: The Journal of Near-Patient Testing and Technology 2014; 13(4): 125–127. 

Mifsud EM, Wirth F, Camilleri L, Azzopardi LM, Serracino-Inglott A. Pharmacist-led medicine use review in community pharmacy for patients on warfarin. Int J Clin Pharm. 2019 [Epub ahead of print]. 

Mifsud M, Vella J, Ferrito V, Serracino-Inglott A, Azzopardi LM, Sammut Bartolo N, LaFerla G, Sammut C. A simple HPLC-UV method for the determination of clindamycin in human plasma. Journal of Chemical and Pharmaceutical Research, 2014, 6(1): 696-704.

Mifsud-Buhagiar L, Cassar OA, Brincat MP, Buttigieg GG, Serracino-Inglott A, Zarb-Adami M, Azzopardi LM. Pre‑operative pain sensitivity: A prediction of post‑operative outcome in the obstetric population. Journal of Anaesthesiology Clinical Pharmacology 2013; 29(4): 465-471. 

Mifsud-Buhagiar L, Scorpiniti M, Sammut Bartolo N, Vella Szijj J, Ferrito V, Serracino-Inglott A, LaFerla G. Implications of mobile phase composition and pH on the chromatographic separation of amitriptyline and its metabolite nortriptyline. Int J Pharm Pharm Sci, 2018; 10(4):132-8 

Muscat Terribile C, Wirth F, Zammit MC, Vella J, Azzopardi LM, Serracino-Inglott A. Evaluation of a Quality System Developed for Pharmacy Teaching Laboratories. Pharmacy Education, 2013; 13 (1): 134 - 139. 

Pace A, Azzopardi LM, Serracino-Inglott A, Wismayer L, Zarb Adami M. Development in the European Union and Access to Medicines. Pharmacie Globale (IJCP) 2013; 4(6): 1-7. 

Pace Bardon C, Shoemake C, Azzopardi LM, Serracino-Inglott A. Investigating the Anti-Oestrogenic Effect of p-Synephrine and de novo design of Oestrogen Receptor Modulating Molecules. BioMirror 2013; Volume 4(8): 5-12.

Pirotta I, Serracino-Inglott A, Azzopardi LM, Anastasi A. Patient knowledge of colorectal cancer therapy side effects. Hospital Pharmacy Europe 2011; 58: 24-26.

Pizzuto M, Portelli J, Serracino-Inglott A, Zarb-Adami M, Azzopardi LM. Chronopharmacology of antihypertensives. Journal of Applied Therapeutic Research. 2010; 7(4):  133-140.

Portelli G, Shoemake CM. The Design and Optimisation of Novel Human Dihydrofolate Reductase Inhibitors for the Management of Proliferative Disease. 2015; 6(9): 92-99.

Portelli S, Shoemake C, Azzopardi LM. In Silico Identification Of A Potentially Novel Binding Modality For 1,3-Dicarbonyl Compounds Having 2(3H)-Benzazolonic Heterocycles Within The PPARγ Ligand Binding Pocket: A De Novo Design Study. BioMirror 2014; 5(1): 1-7.  

Sacco R, Azzopardi LM, Serracino-Inglott A. Palliative care in cancer patients: evaluating pharmacist intervention in a hospice setting. European Journal of Hospital Pharmacy 2011; 17(3): 75-80.

Said C, Coleiro B, Zarb-Adami M, Azzopardi LM, Serracino-Inglott A. Cost Effectiveness of TNF-α Inhibitors in Rheumatoid Arthritis. International Journal of Inflammation 2013.

Sapiano K, Savona-Ventura C, Calleja-Agius J, Serracino-Inglott A, Azzopardi LM. Attitudes towards preconception care in Maltese women with type 1 diabetes mellitus. Gynecol Endocrinol. 2012 Jul 21. [Epub ahead of print]

Schembri M, Shoemake C, Sant-Fournier MA. Drug Design of Novel Molecules Using a Bioisosteric and De Novo Techniques - A comparison. BioMirror 2014; 5(9): 59-68.

Sciberras R, Shoemake C. Optimization of In Silico Designed Fatty Acid Synthase Modulators Derived From the Lead Molecule Orlistat. Imperial Journal of Interdisciplinary Research (IJIR) 2016; 2(9): 1808-14. 

Serracino-Inglott A, Farrugia S, Ferrito MN. Prevalence and Drug Treatment of the Parkinsonian Syndrome in Malta. Dement Geriatr Cogn Disord 1992; 3(1): 47–57. 

Spiteri M, Attard E, Serracino-Inglott A, Azzopardi LM. Compilation of a herbal medicine formulary for herbal substances in Malta and its usefulness amongst healthcare professionals. Journal of Young Pharmacists 2013; 5: 22-25. 

Sultana G, Shoemake C, Camilleri L. Compilation, Validation and Evaluation of a 2D/3D Molecular Database as an Adjunct to Didactic Teaching Modalities. Literacy Information and Computer Education Journal (LICEJ) 2017; 8(2): 2553-2561.

Tanti A, Serracino-Inglott A, Borg JJ. Designing a national combined reporting form for adverse drug reactions and medication errors. East Mediterr Health J. 2015. 

Ungaro S, Wirth F, Azzopardi LM, Serracino-Inglott A. Point-of-Care Testing for Urine Analysis and Microalbuminuria for Diabetic Patient Management. Point of Care: The Journal of Near-Patient Testing & Technology. 14(3):71-72, September 2015.

Vella E, Azzopardi LM, Zarb-Adami M, Serracino-Inglott A. Development of protocols for the provision of headache and back-pain treatments in Maltese community pharmacies. Int J Pharm Pract 2009; 17: 269-274.

Vella J, Busuttil F, Sammut Bartolo N, Sammut C, Ferrito V, Serracino-Inglott A, Azzopardi LM, Laferla G. A simple HPLC–UV method for the determination of ciprofloxacin in human plasma. Journal of Chromatography 2015; 989: 80–85.

Vella J, Mifsud M, Sammut Bartolo N, Ferrito V, Serracino-Inglott A, Azzopardi LM, Laferla G. The combined effects of pH and acetonitrile composition on the separation of two lincosamide antibiotics. Asian Journal of Pharmaceutical and Clinical Research 2014; 7(5): 96-100. 

Vella J, Vella M, Cassar K, Camilleri L, Serracino-Inglott A, Azzopardi LM, Laferla G.  Factors affecting penetration of ciprofloxacin in lower extremity ischeamic tissues.  Int J Lower Extremity Wounds 2015. 

Vella J, Wirth F, Azzopardi LM, Serracino-Inglott A. Serum digoxin concentrations: A retrospective analysis. J Pharmacol Clin Toxicol 2018; 6(7):1129 (5 pages). 

Vella M, Grima M, Wirth F, Attard Pizzuto M, Sammut Bartolo N, Vella J, Azzopardi LM. Consumer perception of community pharmacist extended professional services. Journal of Pharmaceutical Health Services Research 2015; 6(2): 91–96. 

Wirth F, Azzopardi LM, Gauci M, Zarb-Adami M, Serracino-Inglott A. Time and motion study for pharmacists’ activities in a geriatric hospital. Int J Pharm Pract 2009; 17: 373-376.

Wirth F, Tabone F, Azzopardi LM, Gauci M, Zarb Adami M, Serracino Inglott A. Consumer perception of the community pharmacist and community pharmacy services in Malta. Journal of Pharmaceutical Health Services Research 2010; 1(4): 189-194.

Wirth F, Zahra G, Xuereb RG, Barbara C, Camilleri L, Fenech A et alCYP2C19 *2 allele carrier status and coronary in-stent restenosis: Is there an association? J Explor Res Pharmacol 2018;3(2):55-60.

Wirth F, Zahra G, Xuereb RG, Barbara C, Camilleri L, Fenech A, et al. CYP2C19 genetic polymorphisms in Maltese patients on clopidogrel therapy. MMJ. 2018; 30 (2): 14-20.  

Wirth F, Zahra G, Xuereb RG, Barbara C, Fenech A, Azzopardi LM. Comparison of a rapid point-of-care and two laboratory-based CYP2C19*2 genotyping assays for personalisation of antiplatelet therapy. Int J Clin Pharm 2016;38(2):414–420.

Woods M, Shoemake C. Design and Optimization of K-Ras Protein Inhibitors as Anti-Cancer agents using Deltarasin as a Case Study. American Journal of Pharmacy and Health Research 2017; 5(7): 73-81.

Zammit G, Farrugia R, Barbara C, Azzopardi LM, Serracino-Inglott A, Zarb-Adami M, Grech V. Anticoagulation services in Malta – an economic study comparing a central laboratory model vs. a point-of-care approach. Int. Jnl. Lab. Hem. 2010. Dec. 1-2.

Zammit M, Shoemake C, Attard E, Azzopardi LM. The Effects of Anabasine and the Alkaloid Extract of Nicotiana glauca on Lepidopterous Larvae. International Journal of Biology 2014; 6(3): 47-53. 

Zammit MC, Fiorentino L, Cassar K, Azzopardi LM, LaFerla G. Factors Affecting Gentamicin Penetration in Lower Extremity Ischemic Tissues With Ulcers. International Journal of Lower Extremity Wounds. 2011. Aug. 19.


Calendar
Notices
Pharm.D. Programme

Postgraduate Programme leading to Doctorate in Pharmacy 

Read more here

 
 

Log In back to UoM Homepage